Page last updated: 2024-09-04

carbapenems and ljc 10627

carbapenems has been researched along with ljc 10627 in 46 studies

Compound Research Comparison

Studies (carbapenems)	Trials (carbapenems)	Recent Studies (post-2010) (carbapenems)	Studies (ljc 10627)	Trials (ljc 10627)	Recent Studies (post-2010) (ljc 10627)
7,355	147	5,277	176	31	52

Research

Studies (46)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	20 (43.48)	18.2507
2000's	12 (26.09)	29.6817
2010's	10 (21.74)	24.3611
2020's	4 (8.70)	2.80

Authors

Authors	Studies
Lahnborg, G; Nord, CE	1
Ichihara, Y; Mikami, Y; Miyaji, M; Nishimura, C; Ohashi, S; Yazawa, K	1
Chin, NX; Fang, W; Gu, JW; Neu, HC	1
Furukawa, Y; Hikida, M; Kawashima, K; Kuwao, S; Nishiki, K; Nishizawa, K; Saito, I	1
Kamei, C; Kitazumi, K; Tasaka, K; Tsujimoto, S; Yoshida, T	1
Jacobus, NV; Petersen, PJ; Testa, RT; Weiss, WJ	1
Furukawa, Y; Hikida, M; Konno, M; Mitsuhashi, S; Nishiki, K; Tashiro, K; Ubukata, K; Yoshida, M	1
Mitsuhashi, S; Yoshida, M	1
Andrews, JM; Boswell, FJ; Gill, MJ; Wise, R	1
Livermore, DM; Yeo, SF	1
Ratcliffe, RW; Wildonger, KJ	1
Hashizume, T; Hazumi, N; Kato, Y; Matsuda, K	1
Kumazawa, J; Matsumoto, T; Nagayama, A	1
Kanazawa, K; Nouda, H; Sunagawa, M	1
Hirata, Y; Igari, J; Imafuku, Y; Inoue, M; Ishigo, S; Kawaguchi, R; Kobayashi, I; Kumasaka, K; Matsuoka, K; Murakami, E; Nishino, T; Oguri, T; Ohtaki, Y; Okada, J; Okamoto, E; Saeki, H; Satou, S; Shibano, T; Takahashi, A; Tokuda, K; Uchida, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H	1
Awaya, Y; Fujiue, Y; Kodomari, Y; Kuwabara, M; Muroki, K; Shimizu, S; Watanabe, Y	1
Kanamaru, M; Kozawa, O; Matsumoto, S; Matsuno, H; Minamoto, M; Nagashima, S; Niida, Y; Niwa, M; Takiguchi, Y; Uematsu, T; Yokokawa, M	1
Horii, T; Ichiyama, S; Kobayashi, M; Ohta, M	1
Hirata, Y; Hongo, T; Igari, J; Imafuku, Y; Inoue, M; Kawaguchi, R; Kobayashi, I; Kobayasi, Y; Kumasaka, K; Matsumoto, N; Nakasaki, N; Nishino, T; Oguri, T; Ohtaki, Y; Okada, J; Saeki, H; Sasaki, T; Satou, S; Shibano, T; Takahashi, A; Tokuda, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H	1
Fujimura, S; Gomi, K; Honda, Y; Kikuchi, T; Kobayashi, T; Nukiwa, T; Shoji, S; Takahashi, H; Tokue, Y; Watanabe, A; Yasui, S	1
Aoki, N; Hashimoto, T; Hirata, Y; Hongo, T; Igari, J; Imafuku, Y; Inoue, M; Ishigo, S; Kajimura, K; Kawaguchi, R; Kobayashi, I; Kobayashi, Y; Kumasaka, K; Matsumoto, N; Matsuoka, K; Murakami, E; Nakasaki, N; Nishino, T; Oguri, T; Ohba, Y; Ohtaki, Y; Okada, J; Okamoto, E; Ono, J; Saeki, H; Sasaki, T; Satou, S; Shibano, T; Takahashi, A; Takata, T; Tokuda, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H	1
Endo, H; Jinbo, K; Nishinari, C; Suzuki, Y; Tamura, C	1
Hikida, M; Inoue, M; Okamoato, R; Sato, Y; Terashima, S	1
Araake, M; Hara, T; Hiraishi, T; Miyata, A; Ogawa, H	1
Araake, M; Hara, T; Watabe, H	1
Inoue, M; Kaku, M; Nasu, M; Sagawa, K; Yokoyama, T	1
Guo, H; Xie, D; Xu, D	1
Doi, M; Fujiue, Y; Kuwabara, M; Muroki, K; Shimizu, S; Watanabe, Y; Yano, S	1
Azuma, R; Harada, H; Mori, H; Niikura, H; Omine, M; Sakai, H; Sanada, M; Shimamoto, K	1
Baba, N; Gomi, S; Ohsawa, F; Takeuchi, Y; Watanabe, T; Yamada, M	1
Kobayashi, Y; Sumitani, Y	1
Mikamo, H; Tanaka, K; Watanabe, K; Yamagishi, Y	1
Bonomo, RA; Endimiani, A; Papp-Wallace, KM; Taracila, MA	1
Barszcz, B; Cielecka-Piontek, J; Lewandowska, K; Paczkowska, M	1
Cielecka-Piontek, J; Michalska, K; Pajchel, G; Tyski, S	1
Citron, DM; Goldstein, EJ; Merriam, CV; Tyrrell, KL	1
Fukushima, T; Hiraiwa, Y; Kudo, T; Morinaka, A	1
Amicosante, G; Bottoni, C; Celenza, G; Colapietro, M; Compagnoni, C; Marcoccia, F; Maturo, MG; Perilli, M; Sabatini, A; Segatore, B	1
Kaushik, A; Lamichhane, G; Makkar, N; Pandey, P; Parrish, N; Singh, U	1
Ji, S; Li, C; Li, S; Liang, X; Zhang, F; Zhu, Y	1
Amoh, T; Hirota, K; Hori, K; Igarashi, J; Irie, Y; Kariyama, R; Kumon, H; Miyake, Y; Murakami, K; Suga, H; Viducic, D	1
Basta, LAB; Bianchet, MA; Kumar, P; Lamichhane, G; Lloyd, EP; Mattoo, R; Pan, YH; Saavedra, H; Townsend, CA	1
Li, X; Lu, C; Sun, S; Wang, D; Wang, Y	1
Tiwaskar, M; Vora, A	1
George Priya Doss, C; Gopikrishnan, M	1
Bhaskar, A; Chaturvedi, S; Dwivedi, VP; Ghoshal, A; Kumari, A; Mukhopadhyay, S; Pahuja, I; Shaji, A; Verma, A	1

Reviews

1 review(s) available for carbapenems and ljc 10627

Article	Year
Carbapenems: past, present, and future. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11 Topics: Anti-Bacterial Agents; beta-Alanine; beta-Lactams; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Ertapenem; Humans; Imipenem; Thienamycins	2011

Other Studies

45 other study(ies) available for carbapenems and ljc 10627

Article	Year
Efficacy of L-627, a new carbapenem, in the treatment of experimentally induced intra-abdominal infections in rats. Drugs under experimental and clinical research, 1992, Volume: 18, Issue:10 Topics: Abdomen; Animals; Bacterial Infections; Carbapenems; Disease Models, Animal; Gentamicins; Intestines; Male; Metronidazole; Rats; Rats, Sprague-Dawley; Thienamycins	1992
In-vitro activity of new carbapenem antibiotics: comparative studies with meropenem, L-627 and imipenem against pathogenic Nocardia spp. The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:2 Topics: Carbapenems; Imipenem; Meropenem; Microbial Sensitivity Tests; Nocardia; Thienamycins	1992
In vitro activity and beta-lactamase stability of LJC 10,627. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:7 Topics: beta-Lactamases; Carbapenems; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrolysis; Microbial Sensitivity Tests; Thienamycins	1992
Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibiotic. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:2 Topics: Animals; Carbapenems; Chromatography, High Pressure Liquid; Dipeptidases; Humans; Hydrolysis; Imipenem; In Vitro Techniques; Kidney; Kinetics; Macaca fascicularis; Spectrophotometry, Ultraviolet; Swine; Thienamycins	1992
Comparative study of certain antibiotics on epileptogenic property, including (1Rpi, 5S, 6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)] thio-6-[(R)-1-hydroxyethyl]-1-methyl-carbapenem-3-carboxylate (LJC10627), a carbapenem antibiotic with Journal of pharmacobio-dynamics, 1991, Volume: 14, Issue:9 Topics: Animals; Anti-Bacterial Agents; Carbapenems; Electroencephalography; Epilepsy; Injections, Intravenous; Injections, Intraventricular; Male; Rabbits; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Thienamycins	1991
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:1 Topics: Amikacin; Animals; Bacterial Infections; Bacteroides fragilis; Carbapenems; Ceftazidime; Cilastatin; Ciprofloxacin; Dipeptidases; Drug Therapy, Combination; Escherichia coli; Female; Imipenem; Klebsiella pneumoniae; Metronidazole; Mice; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Thienamycins	1991
In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:6 Topics: Animals; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Ceftazidime; Dipeptidases; Gram-Negative Bacteria; Gram-Positive Bacteria; Hexosyltransferases; Hydrolysis; Imipenem; Kidney; Kinetics; Microbial Sensitivity Tests; Microscopy, Phase-Contrast; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Swine; Thienamycins	1990
In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990, Volume: 9, Issue:8 Topics: Bacteria; beta-Lactamases; Carbapenems; Cefpirome; Ceftazidime; Cephalosporins; Humans; Imipenem; Molecular Structure; Thienamycins	1990
Postantibiotic effects of three carbapenems on Pseudomonas aeruginosa in the presence of lysine. The Journal of antimicrobial chemotherapy, 1995, Volume: 35, Issue:1 Topics: Carbapenems; Imipenem; Lysine; Meropenem; Pseudomonas aeruginosa; Thienamycins	1995
Comparative in-vitro activity of biapenem and other carbapenems against Haemophilus influenzae isolates with known resistance mechanisms to ampicillin. The Journal of antimicrobial chemotherapy, 1994, Volume: 33, Issue:4 Topics: Ampicillin Resistance; Bacterial Typing Techniques; Carbapenems; Culture Media; Haemophilus influenzae; Indoles; Microbial Sensitivity Tests; Ornithine Decarboxylase; Thienamycins; Urease	1994
Heteroaryliumthio substituted carbapenem derivatives: synthesis and in vitro activity of 1 beta-methyl-2-(dihydropyrrolotriazoliumthio)carbapenems. The Journal of antibiotics, 1993, Volume: 46, Issue:12 Topics: Anti-Bacterial Agents; Carbapenems; Dipeptidases; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Structure-Activity Relationship; Thienamycins	1993
Effects of a beta-lactamase inhibitor, sulbactam, on the activity of carbapenems against Pseudomonas aeruginosa. The Journal of antibiotics, 1995, Volume: 48, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Drug Synergism; Enzyme Inhibitors; Imipenem; Meropenem; Pseudomonas aeruginosa; Sulbactam; Thienamycins	1995
Sensitivities to four carbapenems of bacteria isolated from patients with refractory complicated urinary tract infections and the detection of carbapenemase-producing Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins; Urinary Tract Infections	1996
Structure-activity relationships of carbapenem compounds to anti-Haemophilus influenzae activity and affinity for penicillin-binding proteins. Effect of 1 beta-methyl group and C-2 side chain. The Journal of antibiotics, 1997, Volume: 50, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Carrier Proteins; Haemophilus influenzae; Hexosyltransferases; Imipenem; Meropenem; Methylation; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Protein Binding; Structure-Activity Relationship; Thienamycins	1997
[Survey of sensitivities of clinical isolates to antibacterial agents (annual report)]. The Japanese journal of antibiotics, 1997, Volume: 50, Issue:8 Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Cocci; Haemophilus influenzae; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins	1997
[The antimicrobial susceptibilities and serotypes of Pseudomonas aeruginosa isolated from sputum]. The Japanese journal of antibiotics, 1998, Volume: 51, Issue:1 Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Piperacillin; Pseudomonas aeruginosa; Serotyping; Sputum; Thienamycins	1998
Pharmacokinetics and safety of a new parenteral carbapenem antibiotic, biapenem (L-627), in elderly subjects. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:6 Topics: Adult; Age Factors; Aged; Area Under Curve; Carbapenems; Female; Humans; Male; Metabolic Clearance Rate; Thienamycins	1998
Relationship between morphological changes and endotoxin release induced by carbapenems in Pseudomonas aeruginosa. Journal of medical microbiology, 1999, Volume: 48, Issue:3 Topics: Carbapenems; Endotoxins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	1999
[Survey of the sensitivities of clinical isolates to antibacterial agents (annual report)]. The Japanese journal of antibiotics, 1999, Volume: 52, Issue:4 Topics: Carbapenems; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Time Factors	1999
[In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998]. The Japanese journal of antibiotics, 1999, Volume: 52, Issue:12 Topics: Bacteria; Carbapenems; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Penicillins; Piperacillin; Respiratory Tract Infections; Thienamycins; Time Factors	1999
[Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents]. The Japanese journal of antibiotics, 2000, Volume: 53, Issue:3 Topics: Bacteria; Carbapenems; Drug Resistance, Microbial; Humans; Imipenem; Japan; Meropenem; Multicenter Studies as Topic; Thienamycins; Time Factors	2000
[Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains]. The Japanese journal of antibiotics, 2001, Volume: 54, Issue:9 Topics: Bacteria; Carbapenems; Cefepime; Cefozopran; Cephalosporins; Imipenem; Meropenem; Thienamycins	2001
[Comparative antibacterial activity of carbapenems against P. aeruginosa (1)]. The Japanese journal of antibiotics, 2001, Volume: 54, Issue:11 Topics: beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Imipenem; Meropenem; Pseudomonas aeruginosa; Thienamycins	2001
[Bactericidal activity of biapenem against various bacteria]. The Japanese journal of antibiotics, 2001, Volume: 54, Issue:12 Topics: Bacteria; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Thienamycins; Time Factors	2001
[Antibacterial activity of biapenem against recent clinical isolates]. The Japanese journal of antibiotics, 2003, Volume: 56, Issue:2 Topics: Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Thienamycins	2003
[Proper use of carbapenem antibiotics based on the feature in the treatment of infectious diseases (discussion)]]. The Japanese journal of antibiotics, 2004, Volume: 57, Issue:1 Topics: Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Thienamycins; Treatment Failure	2004
Catalytic mechanism of class B2 metallo-beta-lactamase. The Journal of biological chemistry, 2006, Mar-31, Volume: 281, Issue:13 Topics: Aeromonas hydrophila; Aspartic Acid; Bacterial Proteins; beta-Lactamases; Binding Sites; Carbapenems; Catalysis; Hydrolysis; Ligands; Models, Chemical; Models, Molecular; Models, Theoretical; Protein Binding; Protein Conformation; Protons; Quantum Theory; Thermodynamics; Thienamycins; Water; Zinc	2006
[Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from urine at one hospital to mainly carbapenem and fluoroquinolone drugs]. The Japanese journal of antibiotics, 2006, Volume: 59, Issue:2 Topics: Amikacin; Anti-Infective Agents; Carbapenems; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Meropenem; Oxazines; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Urine	2006
[Clinical evaluation of biapenem for febrile neutropenia in patients with hematological disorders]. The Japanese journal of antibiotics, 2007, Volume: 60, Issue:2 Topics: Anemia, Aplastic; Carbapenems; Fever; Hematologic Diseases; Humans; Infusions, Intravenous; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Myelodysplastic Syndromes; Neutropenia; Thienamycins; Treatment Outcome	2007
Crystal structures of biapenem and tebipenem complexed with penicillin-binding proteins 2X and 1A from Streptococcus pneumoniae. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Binding Sites; Carbapenems; Crystallization; Crystallography, X-Ray; Models, Molecular; Molecular Structure; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Streptococcus pneumoniae; Thienamycins	2008
[Analysis on the effective dosage regimens for meropenem, biapenem and doripenem against P. aeruginosa infection based on pharmacokinetics and pharmacodynamics theory]. The Japanese journal of antibiotics, 2007, Volume: 60, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Meropenem; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2007
[Clinical investigation on target value of T>MIC in carbapenems]. The Japanese journal of antibiotics, 2008, Volume: 61, Issue:2 Topics: Adult; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Drug Administration Schedule; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Meropenem; Middle Aged; Pelvic Inflammatory Disease; Staphylococcus aureus; Thienamycins	2008
The use of UV, FT-IR and Raman spectra for the identification of the newest penem analogs: solutions based on mathematic procedure and the density functional theory. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2013, Feb-15, Volume: 103 Topics: beta-Lactams; Carbapenems; Doripenem; Models, Molecular; Quantum Theory; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Thienamycins	2013
Determination of biapenem in a medicinal product by micellar electrokinetic chromatography with sweeping in an enhanced electric field. Journal of chromatography. A, 2013, Mar-22, Volume: 1282 Topics: Anti-Infective Agents; Carbapenems; Chromatography, High Pressure Liquid; Chromatography, Micellar Electrokinetic Capillary; Drug Contamination; Limit of Detection; Linear Models; Pharmaceutical Solutions; Reproducibility of Results; Thienamycins	2013
In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; beta-Lactamase Inhibitors; Carbapenems; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Positive Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Prevotella; Serine; Thienamycins	2013
Metallo-β-lactamase inhibitory activity of 3-alkyloxy and 3-amino phthalic acid derivatives and their combination effect with carbapenem. Bioorganic & medicinal chemistry, 2013, Sep-15, Volume: 21, Issue:18 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enzyme Inhibitors; Microbial Sensitivity Tests; Phthalic Acids; Pseudomonas aeruginosa; Structure-Activity Relationship; Thienamycins	2013
Identification of New Natural CphA Metallo-β-Lactamases CphA4 and CphA5 in Aeromonas veronii and Aeromonas hydrophila Isolates from Municipal Sewage in Central Italy. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8 Topics: Aeromonas hydrophila; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Imipenem; Italy; Molecular Sequence Data; Point Mutation; Sewage; Thienamycins	2015
Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10 Topics: Antitubercular Agents; beta-Lactams; Carbapenems; Doripenem; Drug Synergism; Meropenem; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Thienamycins	2015
[Analysis of carbapenems by hydrophilic interaction chromatography and its application]. Se pu = Chinese journal of chromatography, 2015, Volume: 33, Issue:9 Topics: beta-Lactams; Carbapenems; Chromatography; Doripenem; Drinking Water; Ertapenem; Humans; Hydrophobic and Hydrophilic Interactions; Meropenem; Thienamycins	2015
A Pseudomonas aeruginosa Quorum-Sensing autoinducer analog enhances the activity of antibiotics against resistant strains. The journal of medical investigation : JMI, 2017, Volume: 64, Issue:1.2 Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Synergism; Homoserine; Humans; Lactones; Mice; Mice, Inbred ICR; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Thienamycins	2017
Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase Ldt BMC biochemistry, 2017, 05-25, Volume: 18, Issue:1 Topics: beta-Lactams; Carbapenems; Crystallography, X-Ray; Drug Design; Mycobacterium tuberculosis; Peptidyl Transferases; Protein Binding; Thienamycins	2017
In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii. Letters in applied microbiology, 2020, Volume: 70, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ambroxol; Amlodipine; Anti-Bacterial Agents; Carbapenems; Cefoperazone; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins	2020
Biapenem. The Journal of the Association of Physicians of India, 2022, Volume: 70, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Humans; Meropenem; Microbial Sensitivity Tests; Thienamycins	2022
Molecular docking and dynamic approach to screen the drug candidate against the Imipenem-resistant CarO porin in Acinetobacter baumannii. Microbial pathogenesis, 2023, Volume: 177 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Carbapenems; Doripenem; Ertapenem; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Porins	2023
Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis. Microbiology spectrum, 2023, 08-17, Volume: 11, Issue:4 Topics: Animals; Anti-Bacterial Agents; Carbapenems; CD8-Positive T-Lymphocytes; COVID-19; Disease Models, Animal; Immunity; Immunologic Factors; Mice; Mycobacterium tuberculosis; Tuberculosis	2023